Your browser doesn't support javascript.
loading
Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trial.
Nilsson, Caroline; Vereda, Andrea; Borres, Magnus P; Andersson, Mats; Södergren, Eva; Rudengren, Magnus; Smith, Alex; Simon, Reyna J; Ryan, Robert; Fernández-Rivas, Montserrat; Adelman, Daniel; Vickery, Brian P.
Afiliação
  • Nilsson C; Clinical Research and Education, Karolinska Institutet, Sachs' Children and Youth Hospital, Stockholm, Sweden.
  • Vereda A; Aimmune Therapeutics, a Nestlé Health Science Company, London, UK.
  • Borres MP; Karolinska University Hospital, Stockholm, Sweden.
  • Andersson M; Thermo Fisher Scientific, Uppsala, Sweden.
  • Södergren E; Thermo Fisher Scientific, Uppsala, Sweden.
  • Rudengren M; Thermo Fisher Scientific, Uppsala, Sweden.
  • Smith A; Thermo Fisher Scientific, Uppsala, Sweden.
  • Simon RJ; Aimmune Therapeutics, a Nestlé Health Science Company, Brisbane, California, USA.
  • Ryan R; Calico Life Sciences, South San Francisco, California, USA.
  • Fernández-Rivas M; Aimmune Therapeutics, a Nestlé Health Science Company, London, UK.
  • Adelman D; Allergy Department, Hospital Clínico San Carlos, Madrid, Spain.
  • Vickery BP; Aimmune Therapeutics, a Nestlé Health Science Company, Brisbane, California, USA.
Clin Transl Allergy ; 14(1): e12326, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38282192
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article